Loading...

The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

White Paper: Moving Clinical Development Forward in 2023

2023-07-24T21:05:36-04:00Cell & Gene Therapy, News, Thought Leadership|

In today’s cell and gene therapy landscape, there are over 1,400 companies striving to move their products forward into clinic—a critical step in commercializing these groundbreaking treatments. Clinical development is a complex endeavor and the path to market requires careful consideration of factors ranging from chemistry, manufacturing, and controls (CMC) and regulatory strategy to study design, CRO selection, and clinical trial diversity.

(more…)

Read More

White Paper: The Price is Right: Cell and Gene Therapy Approvals and Market Access in 2023

2023-07-24T21:06:01-04:00Cell & Gene Therapy, News, Thought Leadership|

Starting health economic evidence development and market access planning as early as possible in clinical development for a cell and gene therapy is important demonstrating the value to payers and health technology appraisal (HTA) organizations. In a dynamic regulatory and market access landscape, balancing the requirements of regulators and the expectations of payors can be challenging since there is no one-size-fits-all approach.

(more…)

Read More

White Paper: The Future is Now: Cell and Gene Therapy Innovation, Challenges, and Perspectives

2023-07-24T21:06:29-04:00Cell & Gene Therapy, News, Thought Leadership|

Cell and gene therapies have the potential to revolutionize treatment of a wide range of diseases. With six new therapies approved in 2022, including the first allogeneic T-cell therapy, and at least as many slated for approval this year, the sector is poised for rapid growth. This innovation comes with challenges, though, and many consider 2023 to be a seminal year for establishing a strong foothold for advanced therapies in mainstream medicine.

(more…)

Read More

Executive Summary: State of the Industry

2023-07-24T21:06:57-04:00Cell & Gene Therapy, News, Thought Leadership|

Tim Hunt, CEO of the Alliance for Regenerative Medicine (ARM), kicked off the event with a briefing on the state of the cell and gene therapy development landscape. With 475 members worldwide, ARM focuses on convening the sector, providing data and analysis, engaging with stakeholders, and enabling the development of advanced therapies. One of their key initiatives is modernizing healthcare systems to enable access to these novel therapeutics. Highlights of this briefing are provided in this summary.

(more…)

Read More

White Paper: Gene Editing Breakthroughs: A New Hope for Patients

2023-06-20T14:19:37-04:00Cell & Gene Therapy, News, Thought Leadership|

Gene editing technology has rapidly evolved over the past decade. From the initial breakthrough of sequencing the first human genome to researchers today having the ability to create genetically modified mice in as little as four weeks. CRISPR Cas-based gene editing, which acts as a pair of genomic scissors, is at the core of these innovations. The revolutionary technology has enabled rapid genome sequencing and editing to spur advancements in disease research and treatment.

In this white paper, Anshul Mangal President of Project Farma and Precision ADVANCE and Cynthia Pussinen, Advisor & Executive Consulting Partner share how the latest breakthroughs in gene editing technology have the potential to dramatically improve outcomes for patients.

(more…)

Read More

Precision for Medicine Receives Multiple CRO Awards

2023-06-07T13:19:03-04:00News, Press Releases|

Precision for Medicine, a leading biomarker-driven clinical research organization (CRO), received wide recognition at the prestigious 2023 CRO Leadership Awards. The awards acknowledge top CRO partners and are determined by feedback from pharma and biotech sponsors. Precision has been honored in all five categories: Capabilities, Compatibility, Expertise, Quality, and Reliability, securing awards in the Overall, Big Pharma, and Small Pharma categories, along with several distinguished Champion Awards. 

This recognition serves as a testament to our commitment to quality and our clients’ trust in delivering measurable results. 

Read Press Release > 

Read More

Precision Medicine Group Welcomes New General Counsel and Chief Compliance Officer and Chief People Officer

2023-04-26T09:24:19-04:00News, Press Releases|

Bethesda, Md., April 26, 2023 — Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, today announced the appointments of Stacey Hanna, General Counsel and Chief Compliance Officer, and Tina Durocher-Murphy, Chief People Officer. In these roles, Stacey and Tina are responsible for all legal and compliance and human resources functions, respectively, across the enterprise. Both leaders will report directly to Mark Clein, Chief Executive Officer of Precision Medicine Group.

“As Precision Medicine Group innovates and evolves, adding senior-level talent like Tina and Stacey contributes significantly to scaling people, process, and culture for our next phase of growth,” said Clein. “Stacey and Tina are experienced leaders who have proven track records to ensure that our people and processes are well connected to and supported for our growth trajectory.”

(more…)

Read More

Precision Value & Health Acquires Makara Health, Expanding the Company’s Footprint and Communications Capabilities in Europe

2023-04-11T16:26:58-04:00News, Press Releases|

Bethesda, Md., April 12, 2023 — Precision Value & Health, the industry leader in delivering complementary, integrated and specialized capabilities across the commercialization continuum, today announced that it has acquired Makara Health, a UK-based international healthcare communications agency. The move will expand Precision’s European footprint and reinforce the company’s market growth position with its core capabilities in Europe. Founded in 2013, Makara has capabilities in learning and development, medical and patient education, PR and brand promotion, offering its diverse roster of healthcare client companies high-quality, strategic, scientifically robust programs, as well as creative delivery solutions.

With this acquisition, Makara becomes part of the Precision Value & Health team. The Makara team will work closely with PRECISIONscientia, an agency dedicated to delivering medical and scientific communications that expertly interpret and translate the science of medicine.

(more…)

Read More

Precision for Medicine Expands Advanced Tissue Profiling and Genomic Capabilities with new Houston Laboratory

2023-04-10T16:49:19-04:00News, Press Releases|

Houston is one of seven global Precision specialty labs addressing the rising demand for rapid, comprehensive biomarker data to support the development of advanced therapies and diagnostics

HOUSTON, Tx., April 12, 2023 – Precision for Medicine, the first global biomarker-driven clinical research organization, today announced the expansion of its cell biology and genomics laboratory in Houston, TX, proliferating the company’s global biomarker capabilities and laboratory operations.

(more…)

Read More

White Paper: “Preventative” Gene Therapies: Perspectives on Payer Access Challenges and Solutions

2023-11-09T08:32:51-05:00Cell & Gene Therapy, News, Thought Leadership|

Gene therapies offer hope for patients with severe genetic diseases by providing long-term benefits and even cures. However, the challenges of evaluating the long-term benefits of these therapies from a payer perspective are considerable. This white paper by PRECISIONadvisors highlights the shift of gene therapy research into more prevalent diseases, and outlines how manufacturers and payers can co—create evidence requirements and models to optimize launch success and sustainability.

(more…)

Read More
Load More Posts

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

© Precision Medicine Group, LLC.
All Rights Reserved.